|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▼
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
IBUPROFEN |
M01AE01 |
RO
|
POM + Exemption
|
20-10-2017 |
|
|
VALID
|
|
SILYMARIN |
A05BA03 |
RO
|
POM + Exemption
|
06-10-2020 |
|
|
VALID
|
|
ACORAMIDIS |
C01EB25 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006333 |
10-02-2025 |
VALID
|
|
ADAPALENE, COMBINATIONS |
D10AD53 |
RO
|
POM
|
|
|
|
VALID
|
|
ALECTINIB |
L01ED03 |
RO
|
POM
|
05-01-2021 |
|
|
VALID
|
|
APREPITANT |
A04AD12 |
RO
|
POM
|
23-02-2017 |
|
|
VALID
|
|
ASFOTASE ALFA |
A16AB13 |
RO
|
POM
|
02-05-2016 |
EMEA/H/C/003794 |
28-08-2015 |
VALID
|
|
BROMELAINS |
D03BA03 |
RO
|
POM
|
|
|
|
VALID
|
|
CANNABIDIOL |
N03AX24 |
RO
|
POM
|
23-07-2025 |
|
|
VALID
|
|
CATUMAXOMAB |
L01FX03 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/005697 |
10-02-2025 |
VALID
|
|
CERITINIB |
L01ED02 |
RO
|
POM
|
02-05-2016 |
EMEA/H/C/003819 |
06-05-2015 |
VALID
|
|
CHIKUNGUNYA VACCINES |
J07BX07 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/005797 |
28-06-2024 |
VALID
|
|
CHLORTALIDONE |
C03BA04 |
RO
|
POM
|
|
|
|
VALID
|
|
CLONAZEPAM |
N03AE01 |
RO
|
POM
|
21-07-2025 |
|
|
VALID
|
|
COMBINATIONS OF IMIDAZOLE DERIVATIVES |
G01AF20 |
RO
|
POM
|
|
|
|
VALID
|
|
CONCIZUMAB |
B02BX10 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/005938 |
13-12-2024 |
VALID
|
|
DARVADSTROCEL |
L04AX08 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/004258 |
23-03-2018 |
VALID
|
|
EPLONTERSEN |
N07XX21 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006295 |
06-03-2025 |
VALID
|
|
EPTINEZUMAB |
N02CD05 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005287 |
24-01-2022 |
VALID
|
|
ERYTHROMYCIN, COMBINATIONS |
D10AF52 |
RO
|
POM
|
24-02-2017 |
2247 |
08-10-2001 |
VALID
|
|
FENFLURAMINE |
N03AX26 |
RO
|
POM
|
|
|
|
VALID
|
|
FENOTEROL AND IPRATROPIUM BROMIDE |
R03AL01 |
RO
|
POM
|
|
|
|
VALID
|
|
FINERENONE |
C03DA05 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005200 |
16-02-2022 |
VALID
|
|
FOLLITROPIN DELTA |
G03GA10 |
RO
|
POM
|
|
EMEA/H/C/003994 |
12-12-2016 |
VALID
|
|
FORMOTEROL, GLYCOPYRRONIUM BROMIDE AND BUDESONIDE |
R03AL11 |
RO
|
POM
|
20-11-2023 |
EMEA/H/C/004983 |
09-12-2020 |
VALID
|
|
FUROSEMIDE |
C03CA01 |
RO
|
POM
|
08-08-2025 |
|
|
VALID
|
|
GARADACIMAB |
B06AC07 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006116 |
10-02-2025 |
VALID
|
|
GUANFACINE |
C02AC02 |
RO
|
POM
|
02-05-2016 |
EMEA/H/C/003759 |
17-09-2015 |
VALID
|
|
IMETELSTAT |
L01XX80 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006105 |
07-03-2025 |
VALID
|
|
INDINAVIR |
J05AE02 |
RO
|
POM
|
04-05-2018 |
|
|
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED) |
J07BB02 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006538 |
15-11-2024 |
VALID
|
|
IRBESARTAN |
C09CA04 |
RO
|
POM
|
27-02-2020 |
3037 |
16-12-2002 |
VALID
|
|
IRINOTECAN |
L01CE02 |
RO
|
POM
|
13-07-2023 |
7058 |
08-05-1998 |
VALID
|
|
IVACAFTOR AND TEZACAFTOR |
R07AX31 |
RO
|
POM
|
21-11-2023 |
EMEA/H/C/004682 |
31-10-2018 |
VALID
|
|
IXAZOMIB |
L01XG03 |
RO
|
POM
|
24-04-2017 |
EMEA/H/C/003844 |
21-11-2016 |
VALID
|
|
LAZERTINIB |
L01EB09 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006074 |
20-01-2025 |
VALID
|
|
LOMITAPIDE |
C10AX12 |
RO
|
POM
|
09-12-2024 |
|
|
VALID
|
|
LUMASIRAN |
A16AX18 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005040 |
19-11-2020 |
VALID
|
|
LUTETIUM, ISOTOPE OF MASS 177 |
V09XX00 |
RO
|
POM
|
02-05-2016 |
EMEA/H/C/002749 |
19-06-2015 |
VALID
|
|
MARSTACIMAB |
B02BX11 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006240 |
19-09-2024 |
VALID
|
|
METOCLOPRAMIDE |
A03FA01 |
RO
|
POM
|
11-05-2018 |
595 |
07-06-2000 |
VALID
|
|
MIRVETUXIMAB SORAVTANSINE |
L01FX26 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/005036 |
14-11-2024 |
VALID
|
|
MISOPROSTOL |
G02AD06 |
RO
|
POM
|
|
|
|
VALID
|
|
NEMOLIZUMAB |
D11AH12 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006149 |
12-02-2025 |
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|
|
PALONOSETRON, COMBINATIONS |
A04AA55 |
RO
|
POM
|
|
EMEA/H/C/003728 |
27-05-2015 |
VALID
|
|
PANOBINOSTAT |
L01XH03 |
RO
|
POM
|
02-05-2016 |
EMEA/H/C/003725 |
28-08-2015 |
VALID
|
|
PERTUZUMAB |
L01FD02 |
RO
|
POM
|
|
|
|
VALID
|
|
PHENOBARBITAL |
N03AA02 |
RO
|
POM
|
16-07-2025 |
|
|
VALID
|
|
RELUGOLIX |
L02BX04 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005353 |
29-04-2022 |
VALID
|